Manchester Pharmaceuticals has reported the availability of Chenodal 250mg(chenodiol tablets). The FDA has approved Chenodal for patients suffering from gallstones, in whom, surgery poses an unacceptable health risk
ProImmune has launched CFSE T cell proliferation assays for immunogenicity risk assessment. The new assays form part of ProImmune’s Reveal Immunogenicity system, a suite of tools used in
FDA has granted Emergency Use Authorization (EUA) for DxNA’s 2009 H1N1 influenza virus diagnostic test for use in its GeneSTAT detection platform. The new platform enables fast detection
Clarient and BioView have reported that they will collaborate on studies to validate the clinical utility of a non-invasive test for the early detection of non-small cell lung
Rexahn Pharmaceuticals (Rexahn) and TheraTarget have entered into a joint research collaboration agreement. As per the terms of the agreement, TheraTarget is expected to synthesize and supply Rexahn
Eli Lilly has reported that the FDA has approved Zyprexa Relprevv (Olanzapine) for extended release injectable suspension for the treatment of schizophrenia in adults. Zyprexa Relprevv, a long-acting
Sigma Pharmaceuticals (Sigma) and Neurim Pharmaceuticals (Neurim) have entered into a Licensing Agreement for Circadin, a prolonged release melatonin for primary insomnia, in Australia. Circadin, currently approved for
LyondellBasell Industries has launched a new low density polyethylene (LDPE) resin for use in injection molding and masterbatch applications. The new Lupolen 1800U grade features a balance of
Pfizer Animal Health has reported that its swine influenza vaccine, pH1N1, has been approved by the US Department of Agriculture (USDA) for vaccination of healthy swine, including pregnant
Transcept has received a notice of allowance from the US Patent and Trademark Office (USPTO) for claims under US patent application no 11060641, which covers the composition and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.